Strengths and limitations
T2D
To the best of our knowledge the present study is the first randomized trial to specifically address the effect of a GLP-1R agonist on human coronary stent endothelization using OCT. Moreover, no previous human study has reported on the effect of GLP-1RA on the occurrence of neo-atherosclerosis in subjects with T2D. However, there are several limitations. Firstly, we did not reach the number of participants guided from the sample size calculation and therefore the study may have been underpowered. The sample size calculation of the present study was based on in the OCTAMI trial; [